Literature DB >> 16925526

Variation and infectivity neutralization in influenza.

Marcel Knossow1, John J Skehel.   

Abstract

Worldwide epidemics of influenza are caused by viruses that normally infect other species, particularly waterfowl, and that contain haemagglutinin membrane glycoproteins (HAs) to which the human population has no immunity. Anti-HA immunoglobulins neutralize influenza virus infectivity. In this review we outline structural differences that distinguish the HAs of the 16 antigenic subtypes (H1-16) found in viruses from avian species. We also describe structural changes in HA required for the effective transfer to humans of viruses containing three of them, H1, H2 and H3, in the 1918 (Spanish), the 1957 (Asian) and the 1968 (Hong Kong) pandemics, respectively. In addition, we consider changes that may be required before the current avian H5 viruses could pass from human to human.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16925526      PMCID: PMC1782343          DOI: 10.1111/j.1365-2567.2006.02421.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  59 in total

Review 1.  Recent changes among human influenza viruses.

Authors:  Y P Lin; V Gregory; M Bennett; A Hay
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

2.  H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes.

Authors:  R J Russell; S J Gamblin; L F Haire; D J Stevens; B Xiao; Y Ha; J J Skehel
Journal:  Virology       Date:  2004-08-01       Impact factor: 3.616

3.  High and low efficiency neutralization epitopes on the haemagglutinin of type A influenza virus.

Authors:  D J Schofield; J R Stephenson; N J Dimmock
Journal:  J Gen Virol       Date:  1997-10       Impact factor: 3.891

4.  Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography.

Authors:  M B Eisen; S Sabesan; J J Skehel; D C Wiley
Journal:  Virology       Date:  1997-05-26       Impact factor: 3.616

5.  Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes.

Authors:  C Röhm; N Zhou; J Süss; J Mackenzie; R G Webster
Journal:  Virology       Date:  1996-03-15       Impact factor: 3.616

6.  Antigenic and genetic characterization of current influenza strains.

Authors:  A J Hay; A R Douglas; D B Sparrow; K R Cameron; J J Skehel
Journal:  Eur J Epidemiol       Date:  1994-08       Impact factor: 8.082

Review 7.  Role of the B-cell response in recovery of mice from primary influenza virus infection.

Authors:  W Gerhard; K Mozdzanowska; M Furchner; G Washko; K Maiese
Journal:  Immunol Rev       Date:  1997-10       Impact factor: 12.988

8.  Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.

Authors:  T Bizebard; B Gigant; P Rigolet; B Rasmussen; O Diat; P Bösecke; S A Wharton; J J Skehel; M Knossow
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

9.  Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice.

Authors:  G Palladino; K Mozdzanowska; G Washko; W Gerhard
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  The analysis of the monoclonal immune response to influenza virus. II. The antigenicity of the viral hemagglutinin.

Authors:  W Gerhard
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  82 in total

1.  MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.

Authors:  Surender Khurana; Nitin Verma; Jonathan W Yewdell; Anne Katrin Hilbert; Flora Castellino; Maria Lattanzi; Giuseppe Del Giudice; Rino Rappuoli; Hana Golding
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

2.  Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.

Authors:  Margarita Magro; David Andreu; Paulino Gómez-Puertas; José A Melero; Concepción Palomo
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

3.  Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation.

Authors:  Xiangjun Du; Libo Dong; Yu Lan; Yousong Peng; Aiping Wu; Ye Zhang; Weijuan Huang; Dayan Wang; Min Wang; Yuanji Guo; Yuelong Shu; Taijiao Jiang
Journal:  Nat Commun       Date:  2012-02-28       Impact factor: 14.919

4.  Stalking influenza.

Authors:  Debra M Eckert; Michael S Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

Review 5.  Minding the gap: The impact of B-cell tolerance on the microbial antibody repertoire.

Authors:  Joel Finney; Akiko Watanabe; Garnett Kelsoe; Masayuki Kuraoka
Journal:  Immunol Rev       Date:  2019-09-27       Impact factor: 12.988

6.  Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites.

Authors:  Katie L Winarski; Natalie J Thornburg; Yingchun Yu; Gopal Sapparapu; James E Crowe; Benjamin W Spiller
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

7.  Genetic diversity of hemagglutinin gene of A(H1N1)pdm09 influenza strains isolated in Taiwan and its potential impact on HA-neutralizing epitope interaction.

Authors:  Krzysztof Łepek; Beata Pająk; Paweł Siedlecki; Marcin Niemcewicz; Janusz Kocik; Ho-Sheng Wu; Ji-Rong Yang; Krzysztof Kucharczyk; Bogusław Szewczyk
Journal:  Hum Vaccin Immunother       Date:  2014-01-09       Impact factor: 3.452

8.  Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift.

Authors:  Scott E Hensley; Suman R Das; Adam L Bailey; Loren M Schmidt; Heather D Hickman; Akila Jayaraman; Karthik Viswanathan; Rahul Raman; Ram Sasisekharan; Jack R Bennink; Jonathan W Yewdell
Journal:  Science       Date:  2009-10-30       Impact factor: 47.728

9.  Characterization of quasispecies of pandemic 2009 influenza A virus (A/H1N1/2009) by de novo sequencing using a next-generation DNA sequencer.

Authors:  Makoto Kuroda; Harutaka Katano; Noriko Nakajima; Minoru Tobiume; Akira Ainai; Tsuyoshi Sekizuka; Hideki Hasegawa; Masato Tashiro; Yuko Sasaki; Yoshichika Arakawa; Satoru Hata; Masahide Watanabe; Tetsutaro Sata
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

10.  Glycoprotein B switches conformation during murid herpesvirus 4 entry.

Authors:  Laurent Gillet; Susanna Colaco; Philip G Stevenson
Journal:  J Gen Virol       Date:  2008-06       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.